CPT 31
Alternative Names: CPT-31Latest Information Update: 28 Jan 2024
At a glance
- Originator Navigen Pharmaceuticals
- Class Antivirals; Peptides
- Mechanism of Action Peptide inhibitors; Virus internalisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Jan 2024 No recent reports of development identified for phase-I development in HIV-infections(Prevention) in USA (Parenteral, Injection)
- 28 Jan 2024 No recent reports of development identified for preclinical development in HIV-infections in USA (Parenteral, Injection)
- 07 Dec 2020 Phase-I clinical trials in HIV infections (Prevention) in USA (Parenteral) (NCT04672083)